Sanofi

Sanofi is a global pharmaceutical giant that appears in elsewhere's corpus primarily as a strategic LP and corporate investor in Chinese venture funds and biotech deals. As of 2025-05 reporting, it was among the established industry LPs in Cathay Capital's third innovation fund, alongside TotalEnergies, Valeo, and Paris Aéroport — a grouping chosen for its sector-specific expertise, with Sanofi actively engaging with Cathay portfolio companies like Owkin . More recently, in March 2026, Sanofi also participated as an investor in Helixon Therapeutics' $787 million financing round — then a record for biotech fundraising that year — alongside Dimension Capital, DST Global, Hillhouse Capital, and Pfizer .